Clinical trial
Extension Study to Evaluate Safety and Tolerability of Peginesatide for…
NCT00453973 · Affymax, Industry · Terminated
Key facts
| NCT number | NCT00453973 |
|---|---|
| Title | Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU) |
| Official title | An Open-Label, Multi-Center, Extension Study to Evaluate the Safety and Tolerability of Peginesatide for the Long-Term Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease |
| Lead sponsor | Affymax, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Renal Failure, Chronic Kidney Disease, Anemia |
| Intervention type | Drug |
| Interventions | peginesatide |
| Enrollment | 114 |
| Start date | Nov 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Mar 29, 2007 |
| Last update posted | Jun 29, 2012 |
| Countries | Bulgaria, Poland, Romania, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: